We’re very excited to reconnect as we launch the Amputation Decision Aid website. The website includes a collection of freely available resources to help people make more informed decisions about partial foot amputation due to peripheral arterial disease.
At some point during the research and development phase, we’ve personally connected with well over 100 different people. Some of you will have reached out following a conference, or expressed interest in using these resources in clinical practice. Others will have participated in the expert panels that helped guide this work. Your support and encouragement has been motivating, and a reminder of the need for the resources we’ve developed.
“We want to fundamentally change the way decisions are made about amputation surgery. We want to ensure people have access to meaningful conversations with a healthcare provider; conversations that include accurate and unbiased information about their treatment options, the likely outcomes, as well as the risks. We want to see people supported as they deliberate on such a difficult decision. Only then can people make truly informed decisions about amputation surgery.”
– Associate Professor Michael Dillon, La Trobe University.
We are so pleased to reconnect during this launch of the Amputation Decision Aid, and to encourage you to explore the website and make use of the shared decision-making resources including the:
· Amputation Decision Aid - specifically written for people facing the prospect of partial foot amputation due to peripheral arterial disease. It includes unbiased information about the different options, the likely outcomes, and risks of complications in simple terms that are easily understood.
· Amputation Discussion Guide – a companion resources for healthcare professionals that includes up-to-date research evidence and example conversation starters to facilitate meaningful conversations tailored to the needs of each individual patient.
· Training videos – a series of five, short, animated videos to help healthcare providers learn more about shared decision-making, and how to use our resources in clinical practice.
Given your interest and support over time, we would be grateful if you would:
· Read our launch information on LinkedIn. Please like, comment, and share the article with your colleagues
· Check out our website to learn more
· Promote the website and its resources through your professional networks
· Follow us on Twitter to stay up-to-date with our work. Please like, comment, or retweet our posts
If you’d like further information, please do not hesitate to contact us. We’d love to hear from you.
We would like to take this chance to acknowledge and thank our partners; in particular the generous financial support provided by the American Orthotic Prosthetic Association.
In closing, we wanted to again say thank you for your interest and engagement during the development of these shared decision-making resources. We hope you find the resources valuable. In due course, we would love to hear about your experience using them, and how we might make them better in the years ahead.
Dr. Michael Dillon, PhD. on behalf of the developers.
A unique full time opportunity exists for a Podiatrist to join a dynamic team based at Tamworth to gain experience in High risk foot and generalist podiatry.
Employment Type: Temporary Full Time until 30th June 2022
Position Classification: Podiatrist Level 1 / 2
Remuneration: $64.463 - $93,393 per annumHours Per Week: 38Requisition ID: REQ240413
Applications Close: 6th July 2021
Follow the link to apply: https://jobs.health.nsw.gov.au/hnelhd/jobs/podiatrist-level-1-2-108512?et=2bMiH1lnh
QLD/DD2104369661 - Senior Podiatrist HP4
Closing date of 11.59pm on 5th May 2021
REQ218852 - Podiatrist Level 1 / 2
Closing date of 11:59pm on 6th April 2021.
https://jobs.health.nsw.gov.au/hnelhd (HNE Health Career Portal)
https://healthnswgov.referrals.selectminds.com/ (NSW Health Career Portal)
https://iworkfor.nsw.gov.au/ ( I work for NSW website)
It will also appear on Facebook on 29 March 2021.
Watch this space for virtual and state-based educational and networking opportunities!
The NDSS FootForward initiative launched a new diabetes foot risk stratification tool at the 2020 Australian Diabetes Congress.
A Risk Stratification Pathway categorises people with diabetes into four risk categories (very low, low, moderate and high) and provides a definition of each category. These are linked to actions which provide a guide to services or interventions the person with diabetes should receive and who should deliver that care.
The Active Foot Disease Pathway classifies the main categories of active foot disease that can affect people with diabetes and provides a definition of each category. As with the stratification pathway, it is linked to actions, services and guidance on who is best placed to deliver the required care.
LEAP 2020 – Call For Abstracts
Lightning Presentations – Lower Extremity Amputation Prevention (LEAP) Conference 2020
Conference Theme – Staying in Step: Evidence to practice change.
The Scientific Committee invites submissions of abstracts of original research in the area of the high risk foot. We are seeking presentations on areas that have a strong clinical application, and impact on clinical practice in the assessment, diagnosis and management of the high risk foot that can support clinicians to provide best practice care, and to empower and support their clients. Lightning talks are concise oral presentations of 3 minutes duration, requiring the speaker to focus on the key points of their research.
Abstracts are due no later than 5.00pm AEST, Friday 17th April 2020
Successful applicants will be notified by Monday 1st June 2020
Selection of abstracts for the Scientific Program will be made by the conference committee
Abstract Submission Guidelines:
Authors and affiliations: Authors (Arial, size 12 font. Surname, Initial. Presenting author to be in bold and italics. Affiliations number in superscript. Centred) eg Smith, B1, Doe, J2; Affiliations: (Arial, size 12, Italics font. Organisation, City, Country) eg 1 Department of General Practice, University of Melbourne, Parkville, Australia
Title (max 50 words): The title should be as brief as possible while still conveying the topic and nature of the research
Abstract body (max 250 words)
To include the headings: Background and aims; Methods; Results and Conclusions
Before writing your abstract: Consider the following:
All presenters must be registered to attend the conference. Abstract acceptance will be subject to registration for the conference. Please remember that submitting an abstract does NOT automatically register as a conference delegate. Conference registration can be completed online at a later date.
Please email your submission email@example.com no later than 5:00pm AEST, Friday 17th April 2020.
The APP-HRFG committee has submitted the following recommendations to the MBS Review Taskforce to be considered for plans to modify the MBS in relation to high risk foot services:
5.1.1 Recommendation 1
5.1.3 Recommendation 2:
Referral to a specialist may be necessary if the following is occurring:
5.1.9 Recommendation 5:
5.1.11 Recommendation 6:
6. Education, credentialing and accreditation
6.1.9 Recommendation 20:
6.1.13 Recommendation 22:
7.2.1 Recommendation 24: Development of a wound consumables scheme:
We also ask that members of the taskforce consider the following recommendations:
ANZPAC Podiatry competencies: http://www.anzpac.org.au/files/Podiatry%20Competency%20Standards%20for%20Australia%20and%20New%20Zealand%20V1.1%20211212%20(Final).pdf
International Guidelines for the prevention and management of diabetic foot disease (2019): https://iwgdfguidelines.org/
Foot Forward project (National Association of Diabetes Centres): https://nadc.net.au/foot-forward/
The MBS review into wound management has been released - please see the following link from the wound management working group:
As there are a number of areas of concern regarding HRF, the APP-HRF committee will be providing a submission to the taskforce. We welcome all members to send us your feedback by COB 10th January 2020.